BLT 0.00% 2.6¢ benitec biopharma limited

Ann: Benitec Provides Update on BB-401 Cancer Treatment Program, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,018 Posts.
    lightbulb Created with Sketch. 84
    All of the investigational agents that are currently under development by Benitec employ tissue -
    specific delivery vectors (e.g. AAV9) whereas BB-401 has no delivery vector and was delivered
    intratumorally as a “naked” plasmid
    Stick it in and hope it works?
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.